|
| | Preview | Issue Date | Title | Author(s) |
| 1 | | Apr-2022 | Factors Associated With Advanced Colorectal Neoplasia in Patients With CKD | Roger, Simon D ; Au, E.H.; Wong, G.; Howard, K.; Chapman, J.R.; Castells, A.; Bourke, M.J.; Macaskill, P.; Turner, R.; Lim, W.H.; Lok, C.E.; Diekmann, F.; Cross, N.; Sen, S.; Allen, R.D.; Chadban, S.J.; Pollock, C.A.; Tong, A.; Teixeira-Pinto, A.; Yang, J.Y.H.; Kieu, A.; James, L.; Craig, J.C. |
| 2 | | 18-Sep-2021 | Kidney transplant cortical necrosis observed during pelvic radiation therapy | Roger, Simon D ; Jain, Arunima ; Windsor, Apsara ; Chou, A. |
| 3 | | Sep-2021 | HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety | Roger, Simon D ; Coyne, D.W. |
| 4 | | Aug-2021 | Alopecia areata: A rare side effect of prazosin | Roger, Simon D ; Mangkorntongsakul, Varitsara ; Thilagarajan, Chinthuran ; Arianejad, F.; Howard, V.; Smith, S.D. |
| 5 | | Dec-2020 | Health-related quality of life in people across the spectrum of chronic kidney disease | Roger, Simon D ; Krishnan, A.; Teixeira-Pinto, A.; Lim, W.H.; Howard, K.; Chapman, J.R.; Castells, A.; Bourke, M.J.; Macaskill, P.; Williams, G. |
| 6 | | Nov-2020 | Clinical Management of Hyperkalemia | Roger, Simon D ; Palmer, B.F.; Carrero, J.J.; Clegg, D.J.; Colbert, G.B.; Emmett, M.; Fishbane, Steven ; Hain, D.J.; Lerma, E.; Onuigbo, M.; Rastogi, A.; Spinowitz, B.S.; Weir, M.R. |
| 7 | | Aug-2019 | Hyponatremia in Heart Failure | Roger, Simon D ; Tee, S.L.; Sindone, Andrew ; Atherton, J.; Amerena, J.; D'Emden, M.; Erlich, J.; DePasquale, C. |
| 8 | | Jun-2019 | Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study | Roger, Simon D ; Spinowitz, B.S.; Fishbane, Steven ; Pergola, P.E.; Lerma, E.V.; Butler, J.; von Haehling, S.; Adler, S.H.; Zhao, J.; Singh, B.; Lavin, P.T.; McCullough, P.A.; Kosiborod, M.; Packham, D. |
| 9 | | Jun-2019 | One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study) | Roger, Simon D ; Wong, G.; Hope, R.L.; Howard, K.; Chapman, J.R.; Castells, A.; Bourke, M.J.; Macaskill, P.; Turner, R.; Williams, G.; Lim, W.H.; Lok, C.E.; Diekmann, F.; Cross, N.B.; Sen, S.; Allen, R.D.; Chadban, S.J.; Pollock, C.A.; Tong, A.; Teixeira-Pinto, A.; Yang, J.Y.H.; Williams, N.; Au, E.H.K.; Kieu, A.; James, L.; Craig, J.C. |
| 10 | | Mar-2019 | Nail clubbing in laxative abuse: case report and review of the literature | Roger, Simon D ; Smith, Saxon D ; Charlton, O.A.; Dickison, P. |
| 11 | | Sep-2018 | Beware what lies beneath: a case of a gigantic cutaneous squamous cell carcinoma | Roger, Simon D ; Dickison, P.; Howard, V.; Smith, Saxon D |
| 12 | | Jan-2018 | Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD) | Roger, Simon D ; Wong, A.T.Y.; Mannix, C.; Grantham, J.J.; Allman-Farinelli, M.; Badve, S.V.; Boudville, N.; Byth, K.; Chan, J.; Coulshed, S.; Edwards, M.E.; Erickson, B.J.; Fernando, M.; Foster, S.; Haloob, I.; Harris, D.C.H.; Hawley, C.M.; Hill, J.; Howard, K.; Howell, M.; Jiang, S.H.; Johnson, D.W.; Kline, T.L.; Kumar, K.; Lee, V.W.; Lonergan, M.; Mai, J.; McCloud, P.; Peduto, A.; Rangan, A.; Sud, K.; Torres, V.; Vliayuri, E.; Rangan, G.K. |
| 13 | | Dec-2017 | Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial | Roger, Simon D ; Macdougall, I.C.; Bock, A.H.; Carrera, F.; Eckardt, K.U.; Gaillard, Carlo ; Wyck, D.V.; Meier, Y.; Larroque, S.; Perrin, A. |
| 14 | | Dec-2017 | Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease | Roger, Simon D |
| 15 | | Dec-2017 | Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis | Roger, Simon D ; Tio, M.; Park, H.C.; Choong, H.L.; Goh, B.; Cushway, T.R.; Stevens, V.; Macdougall, I.C. |
| 16 | | Sep-2017 | Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial | Roger, Simon D ; Gaillard, Carlo ; Bock, A.H.; Carrera, F.; Eckardt, K.U.; Van Wyck, David ; Cronin, M.; Meier, Y.; Larroque, S.; Macdougall, I.C. |
| 17 | | Jan-2017 | Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial | Roger, Simon D ; Macdougall, I.C.; Bock, A.H.; Carrera, F.; Eckardt, K.U.; Gaillard, Carlo ; Meier, Y.; Larroque, S.; Van Wyck, David |
| 18 | | Jun-2016 | Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial | Roger, Simon D ; Gaillard, Carlo ; Bock, A.H.; Carrera, F.; Eckardt, K.U.; Van Wyck, David ; Bansal, S.S.; Cronin, M.; Meier, Y.; Larroque, S.; Macdougall, I.C. |
| 19 | | Jun-2016 | A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial | Roger, Simon D ; Brigandi, R.A.; Johnson, B.; Oei, C.; Westerman, M.; Olbina, G.; de Zoysa, J.; Sahay, M.; Cross, N.; McMahon, L.; Guptha, V.; Smolyarchuk, E.A.; Singh, N.; Russ, S.F.; Kumar, S. |
| 20 | | Mar-2016 | Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to? | Roger, Simon D ; Sindone, Andrew ; Erlich, J.; Lee, C.; Newman, Henry ; Suranyi, M. |
| 21 | | Dec-2015 | New data on the safety of IV iron-but why the discrepancy with FIND-CKD? | Roger, Simon D ; MacDougall, I.C. |
| 22 | | Jul-2015 | Peginesatide to manage Anemia in chronic kidney disease patients on peritoneal dialysis | Roger, Simon D ; Zabaneh, Raja; El-Shahawy, Mohamed; Roppolo, Michael; Runyan, Grant ; O'Neil, Janet ; Ping, Qiu |
| 23 | | Jan-2015 | Sodium Zirconium Cyclosilicate in Hyperkalemia | Packham, D.; Rasmussen, H.; Lavin, P.; El-Shahawy, M.; Roger, Simon D ; Block, G.; Qunibi, Wajeh Y ; Pergola, P.; Singh, B. |
| 24 | | Dec-2014 | Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with Hyperkalemia: The HARMONIZE Randomized Clinical Trial | Kosiborod, M.; Rasmussen, H.; Lavin, P.; Qunibi, Wajeh Y ; Spinowitz, B.S.; Packham, D.; Roger, Simon D ; Yang, A.; Lerma, E.; Singh, B. |
| 25 | | Nov-2014 | FIND-CKD: A Randomized Trial of Intravenous Ferric Carboxymaltose Versus Oral Iron in Patients with Chronic Kidney Disease and Iron Deficiency Anaemia. | MacDougall, I.C.; Bock, Andreas ; Carrera, Fernando ; Eckardt, Kai-Uwe ; Gaillard, Carlo ; Van Wyck, David ; Roubert, Bernard ; Nolen, Jacqueline ; Roger, Simon D |
| 26 | | May-2014 | Darbepoetin Alfa once monthly corrects Anaemia in patients with chronic kidney disease not on dialysis | Roger, Simon D ; Kolmakova, Elena ; Fung, Maple ; Malecki, Robert ; Vinhas, Jose ; Dellanna, Frank ; Thomas, Mark ; Manamley, Nick ; Ferenczi, Sandor |
| 27 | | Apr-2014 | The FIND-CKD Study: A randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: Background and rationale | MacDougall, I.C.; Bock, Andreas ; Carrera, Fernando ; Eckardt, Kai-Uwe ; Gaillard, Carlo ; Van Wyck, David ; Cushway, Timothy ; Roger, Simon D |
| 28 | | Feb-2014 | A randomised single-blind study to improve health-related quality of life by treating Anaemia of chronic kidney disease with Aranesp(R) (darbepoetin alfa) in older people: STIMULATE | Roger, Simon D ; Jassal, Sarbjit ; Woodward, Michael ; Soroka, Steven ; McMahon, L.P. |
| 29 | | Sep-2013 | Test performance characteristics of quantitative nucleic acid testing for polyomaviruses in kidney and kidney-pancreas transplant recipients | Myint, T.M.; Turner, R.M.; Craig, J.C.; Cross, N.B.; Kable, K.; Nankivell, B.J.; Chapman, J.R.; Webster, Angela C ; O'Connell, P.; Dwyer, D.E.; Jeoffreys, N.; Roger, Simon D ; Wong, Gordon |
| 30 | | Sep-2013 | ACEIs for cardiovascular risk reduction: Have we taken our eye off the ball? | Sindone, Andrew ; Erlich, Jonathan ; Parkovic, Vlado ; Suranyi, Michael ; Newman, Henry ; Lee, Choon ; Barin, Edward ; Roger, Simon D |
| 31 | | Apr-2013 | Peginesatide for maintenance treatment of Anemia in hemodialysis and nondialysis patients previously treated with Darbepoetin Alfa | Fishbane, Steven ; Roger, Simon D ; Martin, Edward ; Runyan, Grant ; O'Neil, Janet ; Qiu, Ping ; Locatelli, Francesco |
| 32 | | Nov-2012 | Arteriovenous fistula surveillance: Everyone's responsibility | Fedderson, Martin A ; Roger, Simon D |
| 33 | | Apr-2012 | Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: New insights | MacDougall, I.C.; Roger, Simon D ; De Francisco, Angel ; Goldsmith, David J A ; Schellekens, Huub ; Ebbers, Hans ; Jelkmann, Wolfgang ; London, Gérard ; Casadevall, Nicole ; Hörl, Walter H; Kemeny, David M ; Pollock, Carol |
| 34 | | Jan-2012 | Safety, immunogenicity and efficacy of subcutaneous biosimilar Epoetin-Alpha (HX575) in non-dialysis patients with Renal Anemia: a Multi-Center, Randomized, Double-Blind Study | Haag-Weber, Marianne ; Eckardt, Kai-Uwe ; Roger, Simon D ; Vetter, Andrea ; Roth, Karsten |
| 35 |  | Jun-2011 | Test Performance of Faecal Occult Blood Testing for the Detection of Bowel Cancer in People with Chronic Kidney Disease (DETECT) Protocol | Wong, Germaine ; Howard, K.; Chapman, J.R.; Tong, Allison ; Bourke, Michael ; Hayen, Andrew ; Macaskill, P.; Hope, Richard ; Williams, Narelle ; Kieu, Anh ; Allen, Richard ; Chadban, Steven ; Pollock, Carol ; Webster, Angela C ; Roger, Simon D ; Craig, J.C. |
| 36 | | May-2011 | A Randomized Controlled Trial Comparing Intravenous Ferric Carboxymaltose with Oral Iron for Treatment of Iron Deficiency Anaemia of Non-Dialysis- Dependent Chronic Kidney Disease Patients | Qunibi, Wajeh Y ; Martinez, Carlos ; Smith, M.; Benjamin, Joseph ; Mangione, Antoinette ; Roger, Simon D |
| 37 | | May-2011 | Hypercalcaemia as a prodromal feature of indolent pneumocystis jivorecii after renal transplantation | Bency, Rosamma ; Roger, Simon D ; Elder, Grahame J |
| 38 | | Apr-2011 | C.E.R.A. once every 4 weeks corrects Anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis | Roger, Simon D ; Locatelli, Francesco ; Woitas, Rainer ; Laville, Maurice ; Tobe, Sheldon ; Provenzano, Robert ; Golper, Thomas ; Ruangkanchanasetr, Prajej ; Lee, Ho Yung ; Wu, Kwan-Dun ; Ladanyi, Agnes ; Martinez-Castelao, Alberto ; Ulrich, Beyer ; Dougherty, Frank |
| 39 | | Nov-2010 | Diagnosis and management of iron deficiency Anaemia: A clinical update | Pasricha, Sant-Rayn ; Flecknoe-Brown, Stephen ; Allen, Katrina ; Gibson, Peter R ; McMahon, L.P.; Olynyk, John ; Roger, Simon D ; Savoia, Helen ; Tampi, Ramdas ; Thompson, Amanda R ; Wood, Erica ; Robinson, Kathryn |
| 40 | | Jul-2010 | Biosimilars: Current status and future directions | Roger, Simon D |
| 41 | | Mar-2010 | Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial | Roger, Simon D ; McMahon, L.P.; Kent, A.B.; Kerr, Peter ; Healy, H.; Irish, A.B.; Cooper, B.; Kark, A. |
| 42 | | Oct-2009 | Managing Anaemia of chronic kidney disease | Roger, Simon D |
| 43 | | Apr-2009 | Albuminuria: Chasing the message not the messenger | Birn, Henrik ; Roger, Simon D |
| 44 | | Feb-2009 | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants with CKD not Receiving Dialysis | Chonchol, Michel ; Locatelli, Francesco ; Abboud, Hanna E ; De Francisco, Angel ; Jolly, Shivinder ; Kaplan, Mark ; Roger, Simon D ; Sarkar, Shyamal ; Albizem, Moetaz B ; Mix, T.C.; Kubo, Yuni ; Block, Geoffrey A |
| 45 | | Jan-2009 | Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease | Lee, Darren ; Levin, Adeera ; Roger, Simon D ; McMahon, L.P. |
| 46 | | Oct-2008 | Biosimilars: It's not as simple as cost alone | Roger, Simon D ; Goldsmith, David J A |
| 47 | | Aug-2008 | Extended administration of Erythropoiesis-Stimulating Agents for optimising the management of Renal Anaemia: What is the evidence? | Roger, Simon D |
| 48 | | Aug-2008 | A randomised, cross-over study comparing injection site pain with subcutaneous Epoetin Beta and subcutaneous Darbepoetin Alfa in patients with chronic kidney disease | Roger, Simon D ; Suranyi, Michael ; Walker, Rowan ; Disney, Alex ; Isbel, Nicole M ; Kairaitis, Lukas ; Pollock, Carol ; Brown, Fiona G ; Chow, J.; Truman, Matt ; Ulyate, Kellie |
| 49 | | Aug-2007 | Biosimilars: Opportunity or cause for concern? | Roger, Simon D ; Mikhail, Ashraf |
| 50 | | Mar-2007 | Epoetin Trials: Randomised controlled trials don't always mimic observational data | Roger, Simon D ; Levin, Adeera |
| 51 | | Feb-2007 | The kidney: victim or villain in heart failure? | Roger, Simon D |
| 52 | | Oct-2006 | Comparative testing and pharmacovigilance of biosimilars | Locatelli, Francesco ; Roger, Simon D |
| 53 | | Sep-2006 | Implementing iron management clinical practice guidelines in patients with chronic kidney disease having dialysis | Irving, Michelle ; Craig, J.C.; Gallagher, M.P.; McDonald, Stephen ; Polkinghorne, Kevan R ; Walker, Rowan ; Roger, Simon D |
| 54 | | Aug-2006 | Biosimilars: How similar or dissimilar are they? | Roger, Simon D |
| 55 | | May-2006 | Effect of early correction of Anemia on the progression of CKD | Rossert, Jerome ; Levin, Adeera ; Roger, Simon D ; Horl, Walter ; Gassmann-Mayer, Cristiana ; Frei, Dieter ; McClellan, William |
| 56 | | May-2006 | Proton pump inhibitors and acute interstitial nephritis | Geevasinga, Nimeshan ; Coleman, Patrick L ; Webster, Angela C ; Roger, Simon D |
| 57 | | Mar-2006 | Assessment of the Bioequivalence of a Generic Cyclosporine A by a Randomized Controlled Trial in Stable Renal Recipients | Hibberd, Adrian D ; Trevillian, Paul R ; Roger, Simon D ; Wlodarczyk, John H ; Stein, Ann M ; Bohringer, Elizabeth G ; Milson-Hawke, Sally M |
| 58 | | Feb-2006 | Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: Results of the candesartan in heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program | O'Meara, Eileen ; Clayton, Tim ; McEntegart, M.; McMurray, John J V ; Lang, Chim C ; Roger, Simon D ; Young, James B ; Solomon, Scott D ; Granger, Christopher ; Ostergren, Jan ; Olofsson, Bertil ; Michelson, Eric L ; Pocock, Stuart ; Yusuf, Salim ; Swedberg, Karl ; Pfeffer, Marc A |
| 59 | | Jun-2005 | Fistula Dysfunction Secondary to a Subcutaneous Myelomatous Deposit | Boshell, David ; Sabharwal, Rohan ; Keen, Ross ; Coleman, Patrick L ; Vladica, Phillip ; Roger, Simon D |
| 60 | | Mar-2005 | Cinacalcet HCl, An Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis: A Randomized, Double-Blind, Multicenter Study | Lindberg, Jill S ; Culleton, Bruce ; Wong, Gordon ; Borah, Michael F ; Clark, Roderick V ; Shapiro, Warren B ; Roger, Simon D ; Husserl, Fred E ; Klassen, Preston S ; Guo, Matthew D ; Albizem, Moetaz B ; Coburn, Jack W |
| 61 | | Feb-2005 | Rabeprazole-Induced acute interstitial nephritis | Geevasinga, Nimeshan ; Coleman, Patrick L ; Roger, Simon D |
| 62 | | Aug-2004 | Darbepoetin Alfa effectively treats Anemia in patients with chronic kidney disease with De Novo Every-Other-Week administration | Toto, Robert ; Pichette, Vincent ; Navarro, Jesus ; Brenner, Robert ; Carroll, Wendi ; Liu, Wei ; Roger, Simon D |
| 63 | | Aug-2004 | What is the practical conversion dose when changing from Epoetin Alfa to Darbepoetin outside of clinical trials? | Roger, Simon D ; Chen, S.C.; Lawrence, S.; Sorrell, T.C. |
| 64 | | Jun-2004 | Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease | McMahon, L.P.; Roger, Simon D ; Levin, Adeera |
| 65 | | Jan-2004 | Effects of early and late intervention with Epoetin Alpha on left entricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial | Roger, Simon D ; McMahon, L.P.; Clarkson, Anthony ; Disney, Alex ; Harris, D.C.; Hawley, Carmel ; Healy, Helen ; Kerr, Peter ; Lynn, Kevin ; Parnham, Alan ; Pascoe, Roess ; Voss, David ; Walker, R.G.; Levin, Adeera |
| 66 | | Mar-2002 | Epoetin treatment: What are the arguments to expect a beneficial effect on renal disease progression? | Rossert, Jerome ; McClellan, William ; Roger, Simon D ; Verbeelen, Dierik |
| 67 | | Jan-2002 | Contribution of Anaemia to progression of renal disease: A debate | Rossert, Jerome ; McClellan, William ; Roger, Simon D ; Verbeelen, Dierik ; Horl, Walter |
| 68 | | Oct-1997 | Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairment | Roger, Simon D ; Ibels, L.S.; Gyory, A.Z.; Caterson, R.J.; Pollock, C.A.; Mahony, J.F.; Waugh, D.A.; Coulshed, S. |
| 69 | | 1996 | Recombinant Erythropoietin increases blood pressure in experimental hypertension and Uraemia without change in Vascular Cytosolic Calcium | Roger, Simon D ; Fluck, Richard ; McMahon, Aisling ; Raine, Anthony |
| 70 | | Jan-1994 | What is the Value of Measuring Renal Parenchymal Thickness before Renal Biopsy? | Roger, Simon D ; Beale, A.M.; Cattell, W.R.; Webb, J.A. |
| 71 | | Jan-1994 | Modulation of platelet cytosolic calcium during Erythropoietin Therapy in Uraemia | Fluck, Richard ; Roger, Simon D ; McMahon, Aisling ; Raine, Anthony |
| 72 | | Feb-1993 | Autonomic dysfunction and the development of hypertension in patients treated with recombinant Human Erythropoietin (r-HuEPO) | Roger, Simon D ; Baker, Laurence ; Raine, Anthony |
| 73 | | Jan-1993 | Enhanced platelet reactivity with Erythropoietin but not following transfusion in dialysis patients | Roger, Simon D ; Piper, J.; Tucker, B.; Raine, Anthony ; Baker, Laurence ; Kovcas, I.B. |
| 74 | | 1993 | Improvement in anaemia following renal transplantation but not after erythropoietin therapy in a patient with sickle-cell disease | Roger, Simon D ; Thuraisingham, R.C.; Macdougall, I.C.; Cavill, I.; Stephens, A.D.; Baker, L.R.; Raine, Anthony |
| 75 | | Oct-1992 | Effects of oxygen breathing and Erythropoietin on Hypoxic Vasodilation in Uremic Anemia | Roger, Simon D ; Grasty, Marianne ; Baker, Laurence ; Raine, Anthony |
| 76 | | Jan-1992 | Comparison of haemostatic activity in haemodialysis and peritoneal dialysis patients with a novel technique, haemostatometry | Roger, Simon D ; Piper, J.; Tucker, B.; Raine, Anthony ; Baker, Laurence ; Kovcas, I.B. |
| 77 | | Oct-1991 | Effects of Erythropoietin on blood pressure | Raine, Anthony ; Roger, Simon D |
| 78 | | Oct-1991 | Low dose Erythropoietin in maintenance haemodialysis: Improvement in quality of life and reduction in true cost of haemodialysis | Harris, D.C.; Chapman, J.R.; Stewart, J.H.; Lawrence, S.; Roger, Simon D |
| 79 | | Feb-1991 | Hepatitis C virus infection in haemodialysis patients | Roger, Simon D ; Crewe, E.; Cunningham, A.; Harris, D.C. |
| 80 | | 1991 | Desferrioxamine enhances the haemopoietic response to Erythropoietin, but adverse events are common | Roger, Simon D ; Stewart, J.H.; Harris, D.C. |
| 81 | | 1991 | Pseudomonas putrefaciens bacteraemia in a peritoneal dialysis patient | Roger, Simon D ; Chen, S.C.; Lawrence, S.; Sorrell, T.C. |
| 82 | | Dec-1990 | Lead Intoxication in an Anuric Patient: Management by Intraperitoneal EDTA | Roger, Simon D ; Crimmins, Denis ; Yiannikas, C.; Harris, D.C. |
| 83 | | Oct-1989 | Sensitization and renal transplantation in New South Wales | Roger, Simon D ; Hibbins, M.; Wright, J.; Chapman, J.R. |
| 84 | | Oct-1989 | Combined pancreas and kidney transplantation: a pilot study | Roger, Simon D ; Allen, R.D.; Chapman, J.R.; Deane, S.A.; Wilson, T.G.; Ekberg, H.; Stewart, J.H.; Lawrence, S.; Harris, D.C.; Little, J.M. |
Loading...
2
0
20
0
false